Using virtual reality to improve cognition in cancer patients
Study of the Benefits of Immersive Virtual Reality Techniques on the Effects on Cognition in People With Cancer (OncoBRAIN)
This study is testing whether using virtual reality exercises can help cancer patients improve their thinking skills and feel better during chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Consorci Sanitari de Terrassa Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Terrassa) |
| Trial ID | NCT05907265 on ClinicalTrials.gov |
What this trial studies
OncoBRAIN evaluates the impact of an immersive virtual reality intervention designed to enhance cognitive function, emotional well-being, and quality of life in individuals diagnosed with cancer and experiencing chemotherapy-related cognitive deficits. Participants will engage in cognitive, physical activity, and mindfulness exercises through virtual reality. The study aims to compare the cognitive performance and emotional state of those receiving the intervention against a control group not receiving it. The hypothesis is that the experimental group will show significant improvements in cognitive abilities such as memory and attention, as well as overall quality of life.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 who have been diagnosed with cancer and have experienced cognitive complaints following chemotherapy.
Not a fit: Patients currently undergoing chemotherapy or those with pre-existing psychiatric or neurological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance cognitive function and emotional well-being in cancer patients suffering from cognitive deficits.
How similar studies have performed: While immersive virtual reality is a novel approach in this context, similar interventions have shown promise in improving cognitive function in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: A. Over 18 years of age and under 65 years of age B. Diagnosis of cancer C. At least 4 weeks since the last chemotherapy treatment session D. Presence of cognitive complaints after chemotherapy treatment E. Level of primary education to be able to perform the cognitive tests. F. Consent to participate in the study Exclusion Criteria: A. Established diagnosis prior to cancer diagnosis of psychiatric, neurological, neurodevelopmental or systemic disorder causing cognitive deficits. B. Motor or sensory impairments that preclude completion of the program. C. Undergoing chemotherapy treatment
Where this trial is running
Terrassa
- Consorci Sanitari de Terrassa — Terrassa, Spain (Recruiting)
Study contacts
- Study coordinator: Maite Garolera
- Email: mgarolera@cst.cat
- Phone: +34937310007
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.